Navigation Links
Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
Date:7/1/2009

Human Reproduction and Embryology (ESHRE) on June 29, 2009. Abstract no. O-005
  • Behr B, et al Corifollitropin alfa versus recombinant FSH treatment in controlled ovarian stimulation: equal efficacy in terms of oocyte and embryo quality. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on June 29, 2009. Abstract no O-003
  • Doody K et al, Puregon reference-'Success rates of a fixed rFSH/GnRH antagonist protocol are not affected by enodgenous LH levels. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on July 1, 2009. Abstract no. O-255
  • Ledger W et al, Two doses of corifollitropin alfa allow for similar exposure and ovarian response in patients weighing less than or equal to 60 kg and > 60 kg. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on July 1, 2009. Abstract no. O-282
  • Hillensjo T et al, Corifollitropin alfa versus recombinant FSH in a GnRH antagonist protocol for controlled ovarian stimulation in women weighing 60 kg or less. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on June 29, 2009. Abstract no. O-004
  • Fatemi HM et al, The first pilot study with corifollitropin alfa in a long GnRH agonist protocol indicates the development of a large cohort of follicles during the first week of ovarian stimulation. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on July 1, 2009. Abstract no. O-283
  • Frequently Asked Questions About Infertility. American Society for Reproductive Medicine Web site. http://www.asrm.org/Patients/faqs.html
    '/>"/>

    • SOURCE Schering-Plough
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
    2. Schering-Plough Announces Pricing of Senior Notes Offering
    3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
    4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
    5. Schering-Plough Completes Acquisition of Organon BioSciences
    6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
    7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
    8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
    9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
    10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
    11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/6/2009)...RNewswire-FirstCall/ - Microbix Biosystems Inc. (t... the Form 52-109F1 Certification of Annual Filings...d James Long, the Chief Financial Officer (the "Of...onnection with the annual audited financial statem...The Company initially filed the annual financial s...
    (Date:11/6/2009)... Nov. 6 ,, 3Q09 Co... Qutenza(TM) E.U. Marketing Authorization to Astel... in commercial readiness activities Expanded mana...Marketing; and Director, Commercial Operations Ap...nd Audit Committee chairman , Upcoming 2009...
    (Date:11/5/2009)...one hybrid . . . , Fuel economy ratings for th...t the www.fueleconomy.gov web site, which Oak Ri...r the U.S. Department of Energy and the U.S. Envir...icles on the best fuel economy list are hybrid ele...ighway). "This list proves that hybrids have gone ...
    (Date:11/5/2009)...lif., Nov. 5 ThermoGenes...nnovative products for processing and storing adul... quarter of fiscal 2010. ,, For the quarter end...es of $5.2 million, a 15 percent increase over rev...ago. The Company said the key contributors to the ...
    Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
    .... April 20 Advanced Instruments, Inc . today i...mometer as the first true automation-friendly osmo...e Advanced(R) 2020-BIO Multi-Sample Osmometer ...efines -- automation capabilities for osmolality t...Kelly Peterson, Product Manager, Advanced Instrume...
    ...N, April 20 Santaris Pharma announced today,promi... of microRNA-targeted,therapeutics against cancer ...ucleic Acid (LNA) Drug Platform. In both in vitro ...ed LNA-antimiR(R),s demonstrated outstanding,recog...NAs due to their high,specificity and affinity. Th...
    ...ril 20 Psylin Neurosciences Inc., a joint ventu...ceuticals, Inc. and PsychoGenics, Inc. announced t...t of a novel compound, PSN0041, for the treatment ...com/cgi-bin/prnh/20090420/LA01157LOGO ) , , PS...tide hormone library, PHORMOL, was identified as h...
    Other Biology Technology:Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry 2Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry 3LNA-Based RNA oligonucleotides Potently Inhibit Cancer microRNAs 2Psylin Neurosciences Commences Development of Compound for Depression 2Psylin Neurosciences Commences Development of Compound for Depression 3
    (Date:11/6/2009)...sary this month of the publication of On the Origi... Sciences (AIBS) is publishing open access two pee...istoric insights into evolution. , The two articl...rnia, Berkeley, and James T. Costa of Western Caro...t Charles Darwin," appeared in the October issue o...
    (Date:11/6/2009)...9) The Monell Center and the Chinese Academy of S...ional Meeting on Taste and Smell Research. Organiz...eting will be the first international meeting on t...er, Chief Executive Officer, American Association ...sher of Science magazine, will open the meeting wi...
    (Date:11/5/2009)... awarded a training grant in the amount of $2,756,...ntegrative Graduation Education and Research Train... to be awarded to Kent State. The grant, which is ...t Act of 2009, runs through 2014. , The grant fu...quatic resource sensing (EARS). The purpose of the...
    Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Mayo Clinic physician receives first PASSOR Legacy Award 60163 1New American Chemical Society podcast 3A Tiny sea creature and a new medical adhesive 10546 1Stanford researchers awarded 246 27 million to study energy efficiency and human behavior 10541 1Stanford researchers awarded 246 27 million to study energy efficiency and human behavior 10541 2
    ...ll needs both to build new and to degrade old or d...ntracellular systems work in concert to keep the c...eins. When proteins or peptides mutate, they can p...tracellular environment. In Huntington,s disease (...in gene eventually causes the cell to build up int...
    ...cientists has announced a major expansion of a lin...s in living organisms. The expansion provides ter... events that occur when a pathogenic or beneficial...events is crucial for developing new interventions...obes while preserving or encouraging the presence ...
    ...they won,t be able to understand the brain until t...how billions of neurons are interconnected. Now, r...udies have jumped what many believe to be a major ... the connections to a single neuron. , In the Marc...escribe how they modified the deadly rabies virus,...
    Other Biology News:Proteasome activator enhances survival of Huntington's disease neuronal model cells 2Uniform language for describing genes of pathogenic and beneficial microbes 2Uniform language for describing genes of pathogenic and beneficial microbes 3Deconstructing brain wiring, one neuron at a time 2Deconstructing brain wiring, one neuron at a time 3
    Plastic Glove Boxes from Terra Universal, Inc.
    ...w Hummingbird has the ability to quickly and accur...kes it a perfect candidate for inclusion in these ...CX interface supplied with all the Cartesian produ...ore. Hummingbirds ability to copy plates in secon...
    Exhaust Fume Hood from Terra Universal, Inc.
    ...bel IT siRNA Tracker Intracellular Localization Ki... label and deliver siRNA, of your design, in an ef...racking experiments. Subcellular localization and ...n be monitored following introduction of the label...
    Biology Products: